What the Evidence Does NOT Show Because the marketing around these compounds is expansive, it is worth stating explicitly what the published record does not establish: It does not show that cagrilintide is superior, equal, or inferior to tirzepatide no head-to-head trial exists, so any ranking is cross-trial inference
10.1016/S0140-6736(18)31773-2 178
Es comn recuperar parte del peso perdido si se suspende sin un plan de mantenimiento (alimentacin, actividad fsica) acompaado por un especialista
2.0%, p = 0.585), no significant difference was observed
The Weight Loss and Health Beenfits of GLP-1 Therapy Beyond stabilizing blood sugar, GLP-1 receptor agonists offer a wide range of systemic health advantages
Conclusion Emerging research on GLP-1 therapy and male fertility is reshaping how clinicians view the relationship between metabolism and reproduction